ABC | Volume 114, Nº5, May 2020

Review Article Costa et al. The heart and COVID-19 Arq Bras Cardiol. 2020; 114(5):805-816 15. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020 Mar 5. [Epub ahead of print]. 16. Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis. Prog Cardiovasc Dis. 2020 Mar 10;pii:S0033-0620(20)30055-4. [Epub ahead of print]. 17. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. 18. Chen C, Zhou Y, Wang DW. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz. 2020 Mar 5. [Epub ahead of print]. 19. Inciardi RM, Lupi L, Zaccone G, Italia L, RaffoM, Tomasoni D, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020 Mar 27. [Epub ahead of print]. 20. da Silva Costa IBS, Figueiredo CS, Fonseca SMR, Bittar CS, de Carvalho Silva CMD, Rizk SI, et al. Takotsubo syndrome: an overview of pathophysiology, diagnosis and treatment with emphasis on cancer patients. Heart Fail Rev. 2019;24(6):833-46. 21. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020 Mar 27. [Epub ahead of print]. 22. Xu X, Chen P, Wang J, Feng J, Zhou H, Li X, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci. 2020;63(3):457-60. 23. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-3. 24. Liu Z, Xiao X, Wei X, Li J, Yang J, Tan H, et al. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J Med Virol. 2020 Feb 26. [Epub ahead of print]. 25. Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin-Angiotensin-Aldosterone System inhibitors in patients with Covid-19. N Engl J Med. 2020 Mar 30. [Epub ahead of print]. 26. Rice GI, Thomas DA, Grant PJ, Turner AJ, Hooper NM. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J. 2004;383(Pt 1):45-51. 27. Sociedade Brasileira de Cardiologia. SBC Informa. Infecção pelo Coronavírus 2019 (COVID-19); 2020. [Citado 18 mar. 2020]. Disponível em: http://www.cardiol.br/sbcinforma/2020/20200315-comunicado- coronavirus.html. 28. American College of Cardiology. ACC Clinical Bulletin COVID-19 Clinical Guidance For the Cardiovascular Care Team; 2020. 29. Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 inWuhan, China. Allergy. 2020 Feb 19. [Epub ahead of print]. 30. Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 2020 Mar 16;pii:ciaa272. [Epub ahead of print]. 31. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia inWuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13. 32. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020 Feb 28. [Epub ahead of print]. 33. Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID -19) in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):145-51. 34. Feng RM, Zong YN, Cao SM, Xu RH. Current cancer situation in China: good orbadnewsfromthe2018GlobalCancerStatistics?CancerCommun(Lond). 2019;39(1):22. 35. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335-7. 36. AmericanCollegeofCardiology.CardiologyMagazine.Ventriculararrhythmia risk due to hydroxychloroquine-azithromycin treatment for COVID-19; 2020. [Cited in 2020Mar 20] Available from: https://www.acc.org/latest-in- cardiology/articles/2020/03/27/14/00/ventricular-arrhythmia-risk-due-to- hydroxychloroquine-azithromycin-treatment-for-covid-19) 37. Yang F, Wang J, Li W, Xu Y, Wan K, Zeng R, et al. The prognostic value of late gadoliniumenhancement inmyocarditisandclinicallysuspectedmyocarditis: systematic review and meta-analysis. Eur Radiol. 2020 Feb 10. [Epub ahead of print]. 38. Aquaro GD, Perfetti M, Camastra G, Monti L, Dellegrottaglie S, Moro C, et al. Cardiac MR with late gadolinium enhancement in acute myocarditis with preserved systolic function: ITAMY study. J Am Coll Cardiol. 2017;70(16):1977-87. 39. Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, et al. Cardiac involvement inapatientwithcoronavirusdisease(COVID-19).JAMACardiol. 2020Mar 27. [Epub ahead of print]. 40. Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive CareMed. 2020;46(4):586-90. 41. Hosseiny M, Kooraki S, Gholamrezanezhad A, Reddy S, Myers L. Radiology perspective of coronavirus disease 2019 (COVID-19): lessons from severe acute respiratory syndrome and middle east respiratory syndrome. AJR Am J Roentgenol. 2020 Feb 28:1-5. [Epub ahead of print]. 42. ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, FergusonND,CaldwellE,etal.Acuterespiratorydistresssyndrome:theBerlin definition. JAMA. 2012;307(23):2526-33. 43. GageA,HigginsA,LeeR,PanhwarMS,KalraA.Reacquaintingcardiologywith mechanical ventilation in response to the COVID-19 pandemic. JACC Case Rep. 2020Mar 23. [Epub ahead of print]. 44. McIntyre WF, Um KJ, Alhazzani W, Lengyel AP, Hajjar L, Gordon AC, et al. Associationofvasopressinpluscatecholaminevasopressorsvscatecholamines alone with atrial fibrillation in patients with distributive shock: a systematic review andmeta-analysis. JAMA. 2018;319(18):1889-900. 45. Munshi L, Walkey A, Goligher E, Pham T, Uleryk EM, Fan E. Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis. Lancet Respir Med. 2019;7(2):163-72. 46. Brodie D, Bacchetta M. Extracorporeal membrane oxygenation for ARDS in adults. N Engl J Med. 2011;365(20):1905-14. 47. Brodie D, Slutsky AS, Combes A. Extracorporeal life support for adults with respiratoryfailureandrelated i ndications:areview.JAMA. 2019;322(6):557- 68. 48. Pozzi M, Banfi C, Grinberg D, Koffel C, Bendjelid K, Robin J, et al. Veno- arterial extracorporeal membrane oxygenation for cardiogenic shock due to myocarditis in adult patients. J Thorac Dis. 2016;8(7):E495-502. 49. Fan E, Del Sorbo L, Goligher EC, Hodgson CL, Munshi L, Walkey AJ, et al. An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: mechanical ventilation in adult patients with acute respiratory distress syndrome. Am J Respir Crit CareMed. 2017;195(9):1253-63. 50. Rubin EJ, Baden LR, Morrissey S. Audio interview: new research on possible treatments for Covid-19. N Engl J Med. 2020;382(12):e30. 51. Colson P, Rolain JM, Lagier JC, Brouqui P, Raoult D. Chloroquine and hydroxychloroquineasavailableweaponstofightCOVID-19.IntJAntimicrob Agents. 2020:105932. 815